您好,欢迎访问仪器信息网
注册
上海基免实业有限公司

关注

已关注

已认证

粉丝量 0

当前位置: 上海基免 > 生物分子 > 鼻咽癌相关转录调节蛋白抗体

鼻咽癌相关转录调节蛋白抗体

供货周期: 7天
品牌: Abcam
型号: 0.1ml/100μg
货号:
报价: ¥1
留言咨询
产品介绍
鼻咽癌相关转录调节蛋白抗体英文名称  Anti-BRD7 
中文名称  鼻咽癌相关转录调节蛋白抗体 
别    名  75 kDa bromodomain protein; BP75; BRD 7; BRD7; BRD7_HUMAN; Bromodomain containing 7; bromodomain containing protein 7; Bromodomain-containing protein 7; CELTIX 1; CELTIX1; NAG4; Protein CELTIX-1. 
浓    度  1mg/1ml 
规 格  0.2ml/200μg
公司专售鼻咽癌相关转录调节蛋白抗体、肿瘤抑制/凋亡抗体、信号分子抗体、结构蛋白抗体、磷酸化特异抗体、融合蛋白tag抗体、非哺乳动物蛋白抗体、细胞周期蛋白抗体、转录调节蛋白抗体、类固醇受体抗体、膜受体抗体、亚细胞标记抗体、同源结构域蛋白抗体、运输蛋白抗体、生长因子和激素抗体、神经生物抗体、激酶和磷酸化抗体、GDP/GTP结合蛋白抗体、合成降解蛋白抗体、离子通道抗体、淋巴细胞信号抗体、细胞粘附因子抗体、流式抗体等抗体种类,价格合理,品质有保障!      
抗体来源  Rabbit  
克隆类型  polyclonal 
交叉反应  Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Sheep   
产品类型  一抗    
研究领域  肿瘤 细胞生物 信号转导 细胞周期蛋白 表观遗传学  
蛋白分子量  predicted molecular weight: 74kDa 
性    状  Lyophilized or Liquid 
免 疫 原  KLH conjugated synthetic peptide derived from human BRD7 
亚    型  IgG 
纯化方法  affinity purified by Protein A 
储 存 液  Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4 
产品应用   WB=1:100-500  ELISA=1:500-1000  IP=1:20-100  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500 
(石蜡切片需做抗原修复) 
 not yet tested in other applications.
 optimal dilutions/concentrations should be determined by the end user.  
保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 
鼻咽癌相关转录调节蛋白抗体产品介绍 This gene encodes a protein which is a member of the bromodomain-containing protein family. The product of this gene has been identified as a component of one form of the SWI/SNF chromatin remodeling complex, and as a protein which interacts with p53 and is required for p53-dependent oncogene-induced senescence which prevents tumor growth. Pseudogenes have been described on chromosomes 2, 3, 6, 13 and 14. Alternative splicing results in multiple transcript variants. 
Function : Acts both as coactivator and as corepressor. May play a role in chromatin remodeling. Activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. Induces dephosphorylation of GSK3B at 'Tyr-216'. Down-regulates TRIM24-mediated activation of transcriptional activation by AR (By similarity). Transcriptional corepressor that down-regulates the expression of target genes. Binds to target promoters, leading to increased histone H3 acetylation at 'Lys-9' (H3K9ac). Binds to the ESR1 promoter. Recruits BRCA1 and POU2F1 to the ESR1 promoter. Coactivator for TP53-mediated activation of transcription of a set of target genes. Required for TP53-mediated cell-cycle arrest in response to oncogene activation. Promotes acetylation of TP53 at 'Lys-382', and thereby promotes efficient recruitment of TP53 to target promoters. Inhibits cell cycle progression from G1 to S phase.
Subunit : Interacts with TRIM24, PTPN13 and DVL1. Identified in a complex with SMARCA4/BRG1, SMARCC1/BAF155, SMARCE1/BAF57, DPF2/BAF45D and ARID2, subunits of the SWI/SNF-B (PBAF) chromatin remodeling complex (By similarity). Interacts with IRF2 and HNRPUL1. Interacts (via N-terminus) with TP53. Interacts (via C-terminus) with EP300. Interacts with BRCA1. Interacts (via bromo domain) with histone H3 (via N-terminus) acetylated at 'Lys-14' (H3K14ac). Has low affinity for histone H3 acetylated at 'Lys-9' (H3K9ac). Has the highest affinity for histone H3 that is acetylated both at 'Lys-9' (H3K9ac) and at 'Lys-14' (H3K14ac). Has very low affinity for non-acetylated histone H3. Interacts (via bromo domain) with histone H4 (via N-terminus) acetylated at 'Lys-8' (H3K8ac) (in vitro). 
Subcellular Location : Isoform 2: Nucleus.
Similarity : Contains 1 bromo domain.
Database links : UniProtKB/Swiss-Prot: Q9NPI1.1
BRD7可能参与了基因转录调控,是一个核转录调节蛋白。经研究发现BRD7可能是通过Ras/MEK/ERK和Rb/E2F两条通路影响细胞周期的进程,使细胞停滞于G0/G1期,BRD7具有阻止细胞周期进程的作用。BRD7蛋白尤其是在鼻咽癌的发病过程中发挥了十分重要作用,BRD7基因的过表达可通过调节MAPK及Wnt信号通路抑制鼻咽癌的生长,并将鼻咽癌阻滞在G1/S期。
在纯化抗体时需要控制好几个指标,包括纯度、含量及抗体的抗原结合活性。
纯度:在实验的任何阶段,确定抗体溶液纯度的最简单方法是取一部分样本进行SDS-PAGE电泳。凝胶可用考马斯亮蓝染色(灵敏度为0.1—0.5ug/带)或银染(灵敏度1~l0ug/带)。 
定量:如果抗体还不纯,有一个快捷的定量方法,即通过SDS-PAGE电泳分离出轻、重链,然后和已知的标准染色带比较。如果需要分析许多样本,用免疫测定法对抗体定量较容易。如果抗体是经过纯化的,可通过测蛋白总量代替上述两种方法,有一简单的方法,即紫外吸收法。鼻咽癌相关转录调节蛋白抗体的量可通过测280nm处的吸收值来测(10D大致相当于0.75mg/m1的纯化抗体)。
抗原结合活性:一般说来,纯化方法不会引起抗原结合活性的改变。用蛋白G或蛋白A树脂很少导致抗体活性丧失。然而,如果最终抗体产物的作用不如原来所预料的好,检测抗体纯化过程所丢失的活性就极为重要。用一系列滴定法比较纯化的抗体和其原材料的活性,以标定每一步中的总抗体量,这将有助于较好的估计通过纯化所丢失的活性。
工商信息

企业名称

上海基免实业有限公司

企业信息已认证

企业类型

信用代码

310116002801941

成立日期

2013-03-11

注册资本

10

经营范围

联系方式
鼻咽癌相关转录调节蛋白抗体由上海基免实业有限公司为您提供,货号,规格:0.1ml/100μg ,CAS号:,如您想了解更多关于鼻咽癌相关转录调节蛋白抗体价格、鼻咽癌相关转录调节蛋白抗体结构式、批发、用途等信息,欢迎咨询。除供应鼻咽癌相关转录调节蛋白抗体外,还可为您提供植物Ca2+-ATP酶(Ca2+-ATPase)检测试剂盒、黄曲霉毒素B1(AFB1)检测试剂盒、玉米赤霉烯酮(ZEN)检测试剂盒等试剂,公司有专业的客户服务团队,是您值得信赖的合作伙伴,上海基免客户服务电话,售前、售后均可联系。
推荐产品
供应产品
相关品类

上海基免实业有限公司

沟通底价

提交后,商家将派代表为您专人服务

获取验证码

{{maxedution}}s后重新发送

获取多家报价,选型效率提升30%
提交留言
点击提交代表您同意 《用户服务协议》 《隐私政策》 且同意关注厂商展位
联系方式:

公司名称: 上海基免实业有限公司

公司地址: 上海市金山工业区亭卫公路6558号9幢2441室 联系人: 肖菊芳 邮编: 201507

仪器信息网APP

展位手机站